Global capnography devices market set to grow to USD 1694.8 million by 2033 with CAGR 9.7%

From GlobeNewswire: 2024-09-03 04:00:00

The Global Capnography Devices Market is set to grow from USD 671.6 million in 2023 to USD 1694.8 million by 2033, with a CAGR of 9.7%. Capnography devices measure CO2 levels in a patient’s breath in real-time, providing immediate feedback on ventilation effectiveness. The market is driven by technological advancements and a preference for minimally invasive treatments.

The sidestream segment dominates the market with the highest market share, offering benefits such as easy connectivity and fewer sterilization challenges. In terms of application, emergency medicine is expected to grow at the fastest CAGR due to the increasing demand for acute care services and the use of capnography technology in improving ventilation.

Hand-held capnography devices are expected to grow at the fastest CAGR in the forecast period, driven by their portability, versatility, and ease of use in various healthcare settings. North America is projected to hold the largest market share, fueled by the region’s high prevalence of respiratory diseases and increased access to respiratory monitoring solutions.

Asia Pacific is expected to experience significant growth in the capnography devices market due to improved healthcare systems, increased healthcare spending, and growing awareness about capnography technology. Major vendors in the market include Smiths Medical, Dragerwerk AG & Co. KGaA, Masimo, and Medtronic, among others, driving competition and innovation.

Recent developments in the market include partnerships between GE HealthCare and Masimo to enhance wireless pulse oximetry technology. The global capnography devices market is segmented by technology, application, type, and region, providing a comprehensive analysis of market trends, forecasts, and competitive landscape for key players in the industry.



Read more at GlobeNewswire: Global Capnography Devices Market Size To Worth USD 1694.8